Mrs Jocelyn Marie Turner, NP-C | |
22136 Medical Village Dr, Athens, AL 35613-2940 | |
(256) 648-5598 | |
Not Available |
Full Name | Mrs Jocelyn Marie Turner |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 22136 Medical Village Dr, Athens, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881205011 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mrs Jocelyn Marie Turner, NP-C 22136 Medical Village Dr, Athens, AL 35613-2940 Ph: (256) 577-7132 | Mrs Jocelyn Marie Turner, NP-C 22136 Medical Village Dr, Athens, AL 35613-2940 Ph: (256) 648-5598 |
News Archive
River blindness and elephantiasis are debilitating diseases caused by parasitic worms that infect as many as 150 million people worldwide.
Taking into account two common kidney disease tests may greatly enhance doctors' abilities to estimate patients' cardiovascular disease risks, enabling millions of patients to have better preventive cardiovascular care, according to a large international study co-led by researchers at the Johns Hopkins Bloomberg School of Public Health.
When the targeted drug bortezomib stops working in patients with advanced multiple myeloma, the patients survive only an average of five months longer. But a phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising new treatment for such patients, Dana-Farber Cancer Institute researchers say.
In a discovery that could give physicians more control over the actions of medications, researchers at Duke University Medical Center have developed a novel drug pair – a potent anti-coagulant with a matched "antidote."
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announced the grant of a European patent protecting its product acyclovir Lauriad.
› Verified 6 days ago